| Detected | Trial | Change |
|---|---|---|
| 2026-08-08 | NCT03997370 Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast… |
Enrollment increased: 318 -> 350 participants |
| 2026-08-08 | NCT03997370 Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast… |
date change Primary completion pushed: 2027-02-06 -> 2028-03-14 |
| 2026-08-08 | NCT03997370 Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast… |
date change Completion pushed: 2028-02-06 -> 2028-03-14 |
| 2026-08-08 | NCT06580314 Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian… |
Trial sites expanded: 676 -> 695 locations |
| 2026-08-08 | NCT04251052 A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess… |
Trial sites expanded: 549 -> 574 locations |
| 2026-08-08 | NCT05646316 Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb… |
Trial sites expanded: 55 -> 60 locations |
| 2026-08-05 | NCT05174169 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease |
Trial sites expanded: 1063 -> 1066 locations |
| 2026-08-05 | NCT06748222 E-Mindfulness Approaches for Living After Breast Cancer |
Trial sites expanded: 364 -> 383 locations |
| 2026-08-05 | NCT05879926 Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus… |
Trial sites expanded: 1249 -> 1259 locations |
| 2026-07-31 | NCT05896189 Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors |
Enrollment closed, study ongoing |
| 2026-07-29 | NCT03180502 Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in… |
date change Completion pushed: 2026-07-15 -> 2031-07-13 |
| 2026-07-19 | NCT03371719 Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent… |
Primary endpoint(s) modified |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT04852887 | De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype… | Stage I Breast Cancer | Recruiting |
| NCT07097142 | Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients… | Muscle Invasive Bladder Urothelial Carcinoma | Recruiting |
| NCT03180268 | Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II… | Grade 2 Meningioma | Recruiting |
| NCT03801876 | Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer | Clinical Stage I Esophageal Adenocarcinoma AJCC v8 | Recruiting |
| NCT05624996 | Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for… | Locally Advanced Lung Non-Small Cell Carcinoma | Recruiting |
| NCT05946213 | Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients… | Prostate Adenocarcinoma | Recruiting |
| NCT06500455 | Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients… | Anatomic Stage IV Breast Cancer AJCC v8 | Recruiting |
| NCT06500481 | Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for… | Anatomic Stage IV Breast Cancer AJCC v8 | Recruiting |
| NCT06958328 | Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer | Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma | Recruiting |
| NCT07166406 | Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients… | Advanced Hepatocellular Carcinoma | Recruiting |
| NCT04804644 | Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain… | Metastatic Lung Small Cell Carcinoma | Recruiting |
| NCT05879926 | Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus… | Breast Cancer | Recruiting |
| NCT06748222 | E-Mindfulness Approaches for Living After Breast Cancer | Breast Cancer | Recruiting |
| NCT05646316 | Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb… | Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 | Recruiting |
| NCT06580314 | Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian… | Fallopian Tube Endometrioid Adenocarcinoma | Recruiting |
| NCT03367702 | Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating… | Stage II Prostate Adenocarcinoma AJCC v7 | Active, Not Recruiting |
| NCT04095364 | Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage… | Low Grade Fallopian Tube Serous Adenocarcinoma | Active, Not Recruiting |
| NCT05705401 | Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for… | HER2-positive Breast Cancer | Active, Not Recruiting |
| NCT07554573 | Assessment of Biosignature Classification of DCIS for RadioTherapy Benefit Post… | Breast Cancer | Not Yet Recruiting |
| NCT07441681 | Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and… | Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Not Yet Recruiting |
| NCT07452458 | Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the… | Glioblastoma, IDH-Wildtype | Not Yet Recruiting |
| NCT02488967 | Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without… | Breast Adenocarcinoma | Active, Not Recruiting |
| NCT05438212 | Comparing the Addition of Radiation Either Before or After Surgery for Patients With… | Metastatic Malignant Neoplasm in the Brain | Active, Not Recruiting |
| NCT05095376 | Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual… | Glioblastoma | Active, Not Recruiting |
| NCT04134260 | Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation… | Prostate Adenocarcinoma | Active, Not Recruiting |